Atyr Pharma Inc (ATYR)

R&D to Revenue

31694.21%

Fiscal year · Period ending:

ATYR logo

ATYR R&D to Revenue

Latest reported31694.21%
ATYR FY R&D/Revenue (0.00% → 31694.21%)
High-resolution chart · PNG

ATYR r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Atyr Pharma Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
31,694.2105%
23,137.0213%
11,981.0198%
412.1702%
0%
165.385%
3,328.91%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.